Evogene Ltd.

EVGN | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.50

$0.00 (-0.66%)

At close: Sep 18, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.66%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Sep 9, 2026

38.5

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $4.3M

1D Range

0.47 0.50

52W Range

0.37 1.50

Valuation (TTM)

PE -0.55

PB -1.31

EV/EBITDA 0.23

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $2.15

Cash Flow

FCF Yield -268.8%

SBC Adj. FCF Yield -273.1%

SBC Impact -1.6%

Margins

Gross Margin -14.2%

Operating Margin -1035.0%

FCF Margin -884.4%

Growth (CAGR)

Revenue 3Y | 5Y -18.6% | 2.9%

Dil EPS 3Y | 5Y 63.9% | 3.9%

FCF 3Y | 5Y 25.5% | 19.4%

Returns

ROA -67.7%

ROE 762.0%

ROIC -113.7%

Financial Health

Net Cash

$8.68M

Current Ratio 3.57

Interest Coverage -2.73

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Evogene Ltd., along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as h...

Sector Healthcare

Industry Biotechnology

Employees 52

IPO Date Oct 15, 2010

Website www.evogene.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.